Clinical Trials Browser

OTHER × Interventional × Non functioning pancreatic endocrine tumor × Clear all

Non functioning pancreatic endocrine tumor, Thymus Neoplasms

NCT02831179 2017-09-28

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

DermatologicEndocrineGastrointestinalNET

Non functioning pancreatic endocrine tumor, Adrenal Cortex Neoplasms, Carcinoid Tumor, Vipoma, Glucagonoma, Insulinoma, Pheochromocytoma, Somatostatinoma, Zollinger-Ellison Syndrome, Carcinoma, Merkel Cell, Carcinoma, Medullary, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2a, Multiple Endocrine Neoplasia Type 2b

NCT02759718 2016-05-03

CgA

Phase 4 Unknown

111 enrolled

Gastrointestinal

Non functioning pancreatic endocrine tumor, Adenoma, Islet Cell

Clinical Trials

Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

CgA